Paul Hjemdahl

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2026;12(4):647-656
Characteristics, clinical management and outcomes of patients with acute myocardial infarction enrolled or not enrolled in a quality registry
Khedri M; Szummer K; Jacobson SH; Hjemdahl P; Spaak J; Carrero J-J
Article: EUROPEAN HEART JOURNAL OPEN. 2026;6(2):oeag023
Inflammatory and cholesterol risks and rates of major cardiovascular events among patients with atherosclerotic cardiovascular disease in routine care
Mazhar F; Capodanno D; Hjemdahl P; Sjolander A; Gerward S; Mathisen J; Plunde O; Kunadian V; Jernberg T; Carrero J-J
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2025;11(7):993-1003
Characteristics, use of guideline-recommended medical therapies and clinical outcomes of patients with heart failure not enrolled in a quality registry: a comparison with the Swedish Heart Failure Registry
Gonzalez-Ortiz A; Hjemdahl P; Mazhar F; Bosi A; Faucon A-L; Savarese G; Lund LH; Carrero JJ
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2025;11(6):500-508
Comparative effectiveness and safety of dual antiplatelet therapy with ticagrelor vs. clopidogrel in older adults with acute coronary syndrome: a target trial emulation study
Marxer CA; Hjemdahl P; Carrero JJ; Fu EL
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2025;86(3):314-323.e1
Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease
Mazhar F; Fu EL; Faucon A-L; Hjemdahl P; Mathisen J; Muhammad IF; Plunde O; Perkovic V; Tuttle KR; Carrero J-J
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2024;80(10):1571-1580
Statin treatment for primary and secondary prevention in elderly patients-a cross-sectional study in Stockholm, Sweden
Wettermark B; Kalantaripour C; Forslund T; Hjemdahl P
Article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2024;129:e10412
Trends in statin utilization and ischemic heart disease mortality in Lithuania and Sweden, 2000-2020
Treciokiene I; Daukintyte K; Hjemdahl P; Wettermark B
Article: AMERICAN HEART JOURNAL. 2024;269:118-130
Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention
Mazhar F; Hjemdahl P; Sjolander A; Kahan T; Jernberg T; Carrero JJ
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023;32(11):1223-1232
Heterogeneity after harmonisation: A retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries
Komen JJ; Hunt NB; Pottegard A; Hjemdahl P; Wettermark B; Olesen M; Bennie M; Mueller T; Carragher R; Karlstad O; Kjerpeseth LJ; Klungel OH; Forslund T
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2023;81(3):307-317.e1
Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
Trevisan M; Hjemdahl P; Clase CM; de Jong Y; Evans M; Bellocco R; Fu EL; Carrero JJ
Journal article: CIRCULATION. 2023;147:ap430
Role of Cystatin C-based Estimated Glomerular Filtration Rate for Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation
Shin J-I; Xu Y; Ballew S; Bosi A; Hjemdahl P; Grams M; Coresh J; Inker L; Carrero JJ
Article: EUROPEAN HEART JOURNAL. 2022;43(37):3528-3538
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study
Komen JJ; Pottegard A; Mantel-Teeuwisse AK; Forslund T; Hjemdahl P; Wettermark B; Hallas J; Olesen M; Bennie M; Mueller T; Carragher R; Karlstad O; Kjerpeseth LJ; Klungel OH
Article: AMERICAN HEART JOURNAL. 2022;251:78-90
Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronar y hear t disease
Mazhar F; Hjemdahl P; Clase CM; Johnell K; Jernberg T; Carrero JJ
Journal article: ATHEROSCLEROSIS. 2022;355:219-220
Association of combined intensity and adherence to statin/ezetimibe therapy with major adverse cardiovascular outcomes in patients with coronary heart disease
Mazhar F; Hjemdahl P; Clase CM; Johnel K; Jernberg T; Carrero JJ
Journal article: ATHEROSCLEROSIS. 2022;355:219
Intensity of lipid-lowering therapy, adherence and LDL-cholesterol goal attainment in patients with coronary heart disease
Mazhar F; Hjemdahl P; Clase CM; Johnel K; Jernberg T; Carrero JJ
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2022;11(14):e025813
Intensity of and Adherence to Lipid-Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease
Mazhar F; Hjemdahl P; Clase CM; Johnell K; Jernberg T; Sjolander A; Carrero JJ
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(Supplement_3):gfac071.045
MO514: Cardiorenal Outcomes Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation
Mazhar F; Trevisan M; Hjemdahl P; Clase CM; De Jong Y; Evans M; Bellocco R; Fu E; Carrero JJ
Article: HEART. 2022;108(8):613-618
Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
Komen J; Pottegard A; Hjemdahl P; Mantel-Teeuwisse AK; Wettermark B; Hellfritzsch M; Hallas J; Herings R; Smits L; Forslund T; Klungel O
Article: EUROPACE. 2021;23(11):1722-1730
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
Komen JJ; Pottegard A; Mantel-Teeuwisse AK; Forslund T; Hjemdahl P; Wettermark B; Hellfritzsch M; Hallas J; Olesen M; Bennie M; Mueller T; Voss A; Schink T; Haug U; Kollhorst B; Karlstad O; Kjerpeseth LJ; Klungel OH
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(F11):f72-f80
Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
Komen JJ; Heerdink ER; Klungel OH; Mantel-Teeuwisse AK; Forslund T; Wettermark B; Hjemdahl P
Visa fler

Alla övriga publikationer

Conference publication: EUROPEAN HEART JOURNAL. 2025;46
Residual inflammation, cholesterol risks and rates of major cardiovascular events in routinely cared patients with atherosclerotic cardiovascular disease
Mazhar F; Capodanno D; Hjemdahl P; Sjolander A; Gerward S; Mathisen J; Plunde O; Kunadian V; Jernberg T; Carrero JJ
Conference publication: EUROPEAN HEART JOURNAL. 2025;46
Characteristics, clinical management and outcome of AMI patients outside quality registries
Khedri M; Szummer K; Hjemdahl P; Jacobson S; Spaak J; Carrero JJ
Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024;39(12):2117-2119
eGFR calculated from cystatin C: implications for dosing of direct oral anticoagulants
Shin J-I; Ballew S; Bosi A; Hjemdahl P; Grams ME; Coresh J; Inker LA; Carrero J-J
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024;33:101
Comparative Effectiveness and Safety of Dual Antiplatelet Therapy with Ticagrelor vs. Clopidogrel in Older Adults with Acute Coronary Syndrome: A Population-Based Study Using the Target Trial Framework
Marxer CA; Hjemdahl P; Jernberg T; Carrero JJ; Fu EL
Meeting abstract: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2024;35(10):10.1681/asn.2024vjyanv1v
Serum C-reactive Protein and Risk of Major Kidney Outcomes in Adults with Atherosclerotic Cardiovascular Disease Managed in Routine Care
Tuttle KR; Mazhar F; Fu E; Faucon A-L; Hjemdahl P; Mathisen J; Muhammad IF; Plunde O; Perkovic V; Carrero JJ
Book chapter: RECENT DEVELOPMENTS IN THERAPEUTIC DRUG MONITORING AND CLINICAL TOXICOLOGY. 2023;p. 513-514
Importance of Creatinine for Urine Quality Control in Determination of Abused Drugs
Lafolie P; Beck O; Blennow G; Boréus L; Borg S; Elwin C-E; Karlsson L; Odelius G; Hjemdahl P
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(4):557-574
Lessons from 20 years with COX-2 inhibitors: importance of dose-response considerations and fair play in comparative trials
Stiller C-O; Hjemdahl P
Conference publication: ATHEROSCLEROSIS. 2022;355:E301-E302
ASSOCIATION OF COMBINED INTENSITY AND ADHERENCE TO STATIN/EZETIMIBE THERAPY WITH MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE
Mazhar F; Hjemdahl P; Clase CM; Johnel K; Jernberg T; Carrero JJ
Conference publication: ATHEROSCLEROSIS. 2022;355:E301
INTENSITY OF LIPID-LOWERING THERAPY, ADHERENCE AND LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS WITH CORONARY HEART DISEASE
Mazhar F; Hjemdahl P; Clase CM; Johnel K; Jernberg T; Carrero JJ
Conference publication: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37:I371
CARDIORENAL OUTCOMES ASSOCIATED WITH ORAL ANTICOAGULANT USE IN PATIENTS WITH ATRIAL FIBRILLATION
Mazhar F; Trevisan M; Hjemdahl P; Clase CM; De Jong Y; Evans M; Bellocco R; Fu E; Carrero JJ
Letter: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(3):e31
Themultiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events? Response
Komen JJ; Forslund T; Mantel-Teeuwisse AK; Klungel OH; von Euler M; Braunschweig F; Wallen H; Hjemdahl P
Letter: THROMBOSIS RESEARCH. 2020;194:98-100
Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit
Agren A; Edgren G; Hjemdahl P; Gryfelt G; Ostlund A; Wikman A
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:133-134
Non-vitamin K antagonist oral anticoagulant and proton-pump inhibitor cotreatment and the association with upper gastrointestinal bleeds in patients with atrial fibrillation: A multi-database cohort study
Komen J; Pottegard A; Forslund T; Mantel-Teeuwisse A; Wettermark B; Hellfritzsch M; Hallas J; Smits L; Herings R; Hjemdahl P; Klungel O
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020;29:648-649
Long-term adherence and persistence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
Komen J; Heerdink R; Klungel O; Mantel-Teeuwisse A; Forslund T; Wettermark B; Hjemdahl P
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:1848
High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment
Komen JJ; Forslund T; Mantel-Teeuwisse AK; Klungel OH; Wettermark B; Von Euler M; Braunschweig F; Wallen H; Hjemdahl P
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:2949
Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study
Komen JJ; Hjemdahl P; Mantel-Teeuwisse AK; Klungel OH; Wettermark B; Forslund T
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2019;28:206
Antithrombotic treatment preceding ischemic stroke, intracranial hemorrhage, and gastrointestinal bleeds and mortality in patients with atrial fibrillation
Komen JJ; Forslund T; Mantel-Teeuwisse AK; Klungel OH; Wettermark B; Hjemdahl P
Review: LAKARTIDNINGEN. 2018;115:FAH6
[Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs].
Hjemdahl P; Braunschweig F; Holmström M; Johnsson H; von Euler M; Wallén H; Forslund T
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:271
Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience
Forslund T; Komen JJ; Andersen M; Wettermark B; Von Euler M; Mantel-Teeuwisse AK; Braunschweig F; Hjemdahl P
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27:8-9
Association between proton pump inhibitor use and gastrointestinal bleeds in NOAC-treated AF patients
Komen J; Forslund T; Wettermark B; Hjemdahl P; Klungel O; Mantel-Teeuwisse A
Visa fler

Forskningsbidrag

Safety and effectiveness of non-vitamin K antagonist oral anticoagulant (NOAC) and high-intensity lipid lowering therapy in routine Swedish healthcare.
Swedish Heart-Lung Foundation
1 januari 2020 - 31 december 2022
Platelet function and antiplatelet treatment in cardiovascular disease, with special focus on diabetes and peripheral arterial disease.
Swedish Research Council
1 januari 2010 - 31 december 2012

Anställningar

Professor Emeritus, Medicin, Solna, Karolinska Institutet, 2024-2027
Professor, Medicin, Solna, Karolinska Institutet, 2020-2024
Professor, Senior, Medicin, Solna, Karolinska Institutet, 2016-2020
Professor/Överläkare, Medicin, Solna, Karolinska Institutet, 1999-2014
Professor/Överläkare, Inst f labratoriemedicin (K5), Karolinska Institutet, 1999-1999
Professor, Bitr/Överläkare, Inst f labratoriemedicin (K5), Karolinska Institutet, 1997-1998

Examina och utbildning

Docent, Farmakologi, Karolinska Institutet, 1978

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI